| Aug 13 |
Nuwellis GAAP EPS of -$18.85 misses by $10.61, revenue of $2.19M beats by $0.19M
|
| Aug 13 |
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
|
| Aug 12 |
Nuwellis Q2 Earnings Preview
|
| Aug 8 |
Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions
|
| Jul 29 |
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Jul 26 |
Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
|
| Jul 24 |
Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
|
| Jul 24 |
Nuwellis to sell ~0.47M shares at $4.24 in registered direct offering
|
| Jul 24 |
Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules
|
| Jul 23 |
Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024
|
